INTRODUCTION
============

Male-factor infertility apparently accounts for 40% to 50% of infertile complications and may be defined by environmental reasons, infections, immunological or hormonal insufficiencies, while many are regulated by genetic factors ([@r15]; [@r6]; [@r4]; [@r20]). Spermatogenesis is a complex process controlled by thousands of genes, where any change in the expression or function of these genes may lead to spermatogenic failure and male infertility ([@r44]; [@r35]). Identification of stage-specific genes controlling spermatogenesis is thus important.

Previous studies have revealed that *TEX11, TEX12, TEX14* and *TEX15* expression is restricted to germ cells and is not detectable in somatic tissues of humans and mice ([@r33]; [@r1]). Multiple studies have shown that X-linked germ cell-specific genes such as testis-expressed gene 11 (*Tex11*) have significant roles in regulating male fertility ([@r43]; [@r21]). Furthermore, *TEX11* expression has been associated with the onset of spermatogenesis, although restricted to spermatocytes and round spermatids ([@r34]; [@r32]).

The synaptonemal complex (SC) is a large protein structure needed for synapsis and the successful completion of meiotic cell division. Incorrect assembly of this complex in mice results in maturation arrest and infertility ([@r3]; [@r14]; [@r18]), and may similarly lead to infertility, recurrent miscarriage and aneuploidies such as Down syndrome in humans ([@r8]; [@r10]; [@r24]). *Tex11*, *Tex12* and *Tex15* are needed in chromosomal synapsis and meiotic recombination. More specifically, *Tex11* forms distinct foci on homologous chromosomes that synapse with each other and seem to be a new component of meiotic nodules needed for recombination. In the absence of this protein, chromosomal synapsis stops and crossover formation is reduced ([@r29]; [@r38]). *Tex12* is a meiosis-specific protein essential for the progression of synapsis between homologous chromosomes in male and female germ cells ([@r14]). Loss of *Tex15* leads to meiotic recombination failure, since this protein is responsible for the transfer of DNA repair proteins onto double strand break (DSB) locations ([@r37]). *TEX12* is small with no known domains, but has orthologs in other mammals such as mice, cows, and dogs ([@r13]; [@r33]). *TEX15* has orthologs in mammals and zebra fish ([@r37]). It is abundantly expressed in post-meiotic germ cells, spermatogonia, and early spermatocytes, showing that this gene plays a role in different stages of spermatogenesis ([@r37]; [@r34]). Interestingly, it is expressed in both the testis and ovaries, as is its mouse ortholog ([@r33]).

Germ cell intercellular bridges are required for fertility in invertebrates ([@r5]; [@r26]; [@r27]) and have been preserved from invertebrates to humans ([@r9]), indicating their importance in fertility ([@r12]; [@r11]). Mammalian intercellular bridges connect hundreds of germ cells in syncytia originated from a single spermatogonial stem cell ([@r16]; [@r12]; [@r11]). In the absence of cell bridges in mammalians, syncytium is thus not formed and as a result spermatogenesis is impaired ([@r12]; [@r11]). *TEX14* is needed to generate the germ cell intercellular bridges from the midbody ([@r12]). Human *TEX14* is preferentially expressed in the testis with its highest levels observed in spermatocytes and early round spermatids ([@r36]). [@r12] showed that *Tex14-/-* mutant male mice do not form intercellular bridges, thus confirming its essentiality in mammalian spermatogenesis. It was later revealed that *Tex14* is also essential for complete spermatogenesis in Finnish Yorkshire boars as in mice ([@r28]). [@r7] recognized new loci showing association with development of testicular germ cell cancer (TGCT), one of which (rs9905704) located in *TEX14*. It has also been shown that common genetic variations in *TEX14*, which is over-expressed in breast tumors, is associated with risk of breast cancer in Caucasians ([@r17]). Recent studies showed that although *Tex11-/-*, *Tex14-/-* and *Tex15 -/-* mutant male mice were sterile because of meiotic arrest and disturbance of spermatogenesis, mutant females were fertile. They suggested that the infertility observed in mutant male mice was caused by loss of function of these genes and that *Tex11*, *Tex14* and *Tex15* were needed for meiosis progression and fertility only in male mice ([@r37]; [@r12]; [@r28]). However, *TEX12* has identical localization patterns in oocytes and spermatocytes, revealing that this protein is a common part of the central element of the synaptonemal complex in mammals and is not sex-specific ([@r13]). *Tex12 -/-* mutant male mice were azoospermic and therefore sterile because of failure in chromosomal synapsis progression, while *Tex12 -/-* female mice were sterile because of loss of ovarian follicles ([@r14]).

The homology of amino acid sequences and expression patterns of the human and murine *TEX11*, *TEX12, TEX14 and TEX15* genes ([@r33]; [@r43]; [@r32]; [@r30]; [@r12]; [@r36]; [@r13] ; [@r38]) suggests that these genes may play some a few in human spermatogenesis. Given that deficiency of these genes results in azoospermic mice ([@r43]; [@r12]; [@r36]; [@r12]; [@r37]), severe spermatogenic failure may thus be caused by their disruption. Therefore, this study aimed to replicate this finding in humans by examining the expression levels of *TEX11*, *TEX12, TEX14*, and *TEX15* in the testis tissue of patients with non-obstructive azoospermia and comparing them against controls.

MATERIAL AND METHODS
====================

Patients
--------

Twenty-seven tissue samples were obtained from 18 patients with non-obstructive azoospermia (NOA) and nine subjects with obstructive azoospermia. All participating infertile men had undergone testicular sperm extraction (TESE) procedures at the Royan Institute. All patients gave written informed consent and the Ethical Review Board of the Royan Institute approved the study (reference number EC/90/ 1050).

Nine of the 18 patients with NOA were diagnosed with Sertoli cell-only syndromes (SCOS), while the other nine were diagnosed with maturation arrest at the spermatocyte stage. The control group consisted of nine patients with obstructive azoospermia. Patients with abnormal karyotypes and Y chromosome microdeletions were excluded from the study.

The age range of the patients at the time of diagnosis was 30 to 50 years and their mean age was 36.91±5.39 years. Hormonal levels were measured using a competitive ELISA kit (Monobind, CA, USA) according to the procedure described by [@r42]. Cytogenetic analysis was performed based on standard methods ([@r2]).

Histological evaluation
-----------------------

After TESE, a portion of the testicular samples was submerged in Bouin\'s solution and sent for standard histopathological analysis ([@r22]). Residual tissues were collected by the Royan Tissue Bank. Testicular histopathology was categorized according to the most recognized pattern of spermatogenesis process: samples with complete spermatogenesis (obstructive azoospermia), samples with spermatogenic maturation arrest at the spermatocyte stage or SCOS.

RNA extraction
--------------

Total RNA from frozen testis tissue was extracted with TRIzol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer\'s instructions. Approximately 50-100 mg of testis tissue was pipetted into one mL of TRIzol. RNA was detached with chloroform, precipitated with isopropanol, washed with 75% ethanol, and finally dissolved in DEPC treated water ([@r19]).

The concentration of RNA samples was determined spectrophotometrically by measuring absorption at 260 nm ([@r19]), while DNA and protein contamination were checked by optical density (OD) measurements at 260/280 nm.

The integrity of total RNA was evaluated by measuring 260:280 nm absorption ratios and by gel electrophoresis on 1.2% agarose gel ([@r41]; [@r31]).

DNase treatment and cDNA synthesis
----------------------------------

Before total RNA reverse transcription (RT), the samples were treated with DNase to eliminate DNA contamination using the DNase I (RNase free) kit (Fermentas, Life Sciences, UK). Total RNA (2 µg) was reverse-transcribed into cDNA in a reaction primed with random hexamer primers using the RevertAid H Minus First Strand cDNA Synthesis Kit (Fermentas, Life Sciences, UK) according to the manufacturer\'s recommendations. Polymerase chain reaction (PCR) primers for *TEX11, TEX12, TEX14*, and *TEX15* were designed using PerlPrimer v1.1.20 ([Table 1](#t1){ref-type="table"}).

###### 

Oligonucleotide primer sequences

  Gene    Forward primer             Reverse primer             Amplification   Product size with   NCBIReference sequence
  ------- -------------------------- -------------------------- --------------- ------------------- ------------------------
  GAPDH   CTCATTTCCTGGTATGAC AACGA   CTTCCTCTTGTGCTCTTGCT       60              121                 NG-007073.2
  TEX11   GCCTGAATAGAGCCTTTGTGA      TAGATCAACTGCAACTGCCAT      62              250                 NG-012574.1
  TEX12   AGTCTCCAGTGCCAGATAGT       AGATTAATTTCCTTGCTCACATCA   62              135                 NG-012574.1
  TEX14   GGTTTATCCACCGCTCCCTC       CCTCTGTCCTCGCTTTCCAA       62              198                 NG-012574.1
  TEX15   AGGCAACATTCAAGCATCCA       AGTGAGCCAGGTAGTGATCTTT     62              141                 NG-012574.1

After RNA extraction from testis tissue samples and cDNA synthesis, RT-PCR was performed with the related primers to confirm their expression in the samples of the three groups.

Quantitative RT-PCR (RT-qPCR)
-----------------------------

RT-qPCR was carried out to confirm and analyze the expression levels of target genes in the SCOS, MA, and control groups. The reactions were processed on a 7500 Real Time PCR machine (Applied Biosystems, Carlsbad, CA, USA) using the Power SYBR Green PCR master mix (Applied Biosystem, EU). The amplification solution contained 10 µl of Power SYBR Green PCR master mix, 50 ng of cDNA and 5 picomoles of each primer, yielding a final volume of 20 µl. Cycling conditions included an initial step of enzyme activation at 95°C for 10 minutes, followed by 40 cycles of denaturation at 95°C for 15 seconds, annealing at 62°C for 30 seconds, and extension at 72°C for 30 seconds. Transcript levels normalized to human glyceraldehyde 3-phosphate dehydrogenase (*GAPDH*) showed minimum variation among individual samples. *GAPDH* was used as an internal positive control. Each sample was run in duplicate and the mean value was calculated. No primer-dimer formation was observed during PCR amplification.

Immunohistochemistry
--------------------

The expression of *TEX14* was analyzed in the SO/H (n=3), SCOS (n=3), and MA (n=3) groups by immunohistochemistry. First, testis tissue sections were deparaffinized in xylene washes and then rehydrated in descending concentrations of ethanol washes. Endogenous peroxidase activity was blocked for 1 h at 37°C with goat serum (Sigma-Aldrich, St Louis, MO, USA), and triton X 100 was used to permeabilize cell membranes. Primary (*Tex14* Antibody, NBP1-85424 Novus, Biologicals USA, 1:100) and secondary antibodies (goat anti-rabbit HRP, ab97051, 1:100) were added and protein localization was visualized using a Dako Liquid DAB+ Substrate Chromogen System (Dako, Glostrup, Denmark). Finally, cells were imaged using an Olympus IX 71 microscope ([@r45]). Negative controls were generated by the same method as the positive controls; however, the primary antibody was replaced with PBS solution.

Statistical analysis
--------------------

Data on clinical characteristics were shown as mean ± SEM. The normality of variables was analyzed with the Kolmogorov test. Differences in the mean values among the three groups were analyzed by one-way analysis of variance (ANOVA). The tests cited above were performed on SPSS statistical software package (SPSS Inc, Chicago, IL, USA) version 22.0. Real-time data were processed and analyzed using a two-tailed t-test. Differences with *p*-values \<0.05 were considered significant.

RESULTS
=======

Patient clinical characteristics
--------------------------------

The characteristics of patients including age and LH, FSH, and testosterone levels are listed in [Table 2](#t2){ref-type="table"}. There was no significant difference in age, LH or testosterone serum levels between the three groups; however, the FSH serum levels between these groups were signiﬁcantly different (*p*=0.01).

###### 

Clinical characteristics of patient groups. Values are expressed as mean±SEM

  Patients groups                     Age(years)          FSH(mIU/mL)                             LH(mIU/mL)   Testosterone (ng/mL)
  ----------------------------------- ------------------- --------------------------------------- ------------ ----------------------
  Maturation arrest (MA)              37.28±3.28(30-50)   5.62±1.51                               4.32±1.26    5.28±0.84
  Sertoli-cell-only syndrome (SCOS)   37.33±1.20(33-42)   18.57±3.90                              3.73±1.82    3.27±0.59
  Control                             36.33±1.24(30-42)   8.37±1.73                               3.70±0.87    5.61±3.57
  *p*-value                           0.924               0.010[\*](#TFN2){ref-type="table-fn"}   0.941        0.237

Values are expressed as mean±SEM.

Significant difference based on ANOVA. Normal range of FSH: 1.5-12.4 mIU/mL Normal range of LH: 1.0-10.0 mIU/mL Normal range of Testosterone: 2.0-8.0ng/mL

Gene expression analyses
------------------------

The RT-qPCR results demonstrated that transcripts of all four *TEX* genes existed in all samples of the SCOS, MA, and control groups. Differential expression analysis showed that expression of *TEX* genes is significantly lower in SCOS testes samples when compared with controls (*p*\<0.01) ([Figures 1](#f1){ref-type="fig"}-[4](#f4){ref-type="fig"}). The expression of *TEX11* and *TEX14* was also significantly lower in MA samples compared with controls (*p*≤0.038) ([Figures 1](#f1){ref-type="fig"},[3](#f3){ref-type="fig"}); however, expression of *TEX12* and *TEX15* was not significantly different (*TEX12,15 p*\>0.05) ([Figures 2](#f2){ref-type="fig"},[4](#f4){ref-type="fig"}). Expression levels of *TEX12, TEX14* and *TEX15* in SCOS and MA samples were not significantly different (*TEX12*, 14,15 *p*\>0.05) ([Figures 2](#f2){ref-type="fig"},[3](#f3){ref-type="fig"}, and [4](#f4){ref-type="fig"}); however, *TEX11* expression was significantly lower in SCOS samples (*p*=0.003) ([Figure 1](#f1){ref-type="fig"}).

Figure 1Comparison of the expression levels of *TEX11* between MA, SCOS, and control patients. \*\*\* *p*\<0.05

Figure 4Comparison of the expression levels of *TEX15* between MA, SCOS, and control patients. \*\*\* *p*\<0.05

Figure 3Comparison of the expression levels of *TEX14* between MA, SCOS, and control patients. \*\*\* *p*\<0.05

Figure 2Comparison of the expression levels of *TEX12* between MA, SCOS, and control patients. \*\*\* *p*\<0.05

Immunohistochemical analysis of *TEX14* expression
--------------------------------------------------

Immunohistochemical analysis with *TEX14* antibody indicated absence of Leydig cell staining in several testis samples in all three groups. *TEX14* was however detected in a small number of Sertoli cells, averaging 1-2 positive cells per tubule, consistent with the low level of RNA detected by RT-qPCR. The intensity of staining in germ cells of control tissues was higher than in MA tissues ([Figure 5](#f5){ref-type="fig"}). *TEX14* was expressed specifically by germ cells at varying stages of spermatogenesis. Type A spermatogonia (SA), primary spermatocytes (S1), and early round spermatids (S3) were positively stained for *TEX14*. No positive signal was detected in SCOS tissue samples.

Figure 5(A-D) Immunohistochemical analysis of adult testis sections with *TEX14* antibody. (A) *TEX14* is expressed in human testis cross-sections in obstructive azoospermia tissue samples. *TEX14* is expressed specifically by germ cells at varying stages of spermatogenesis. Type A spermatogonia (SA), primary spermatocytes (S1) and early round spermatids (S3) stain positively for *TEX14*. (B) *TEX14* is expressed in human testis cross-sections in MA tissue samples. (C) Negative control of testis cross-sections in MA tissue samples. (D) No positive signal is detected in adult human testis of SCOS tissue samples. The scale bar represents 10µm

DISCUSSION
==========

The same expression pattern of *TEX11, TEX12, TEX14* and *TEX15* genes in mice and humans indicates that these conserved genes may have an important role in the early stages of mammalian spermatogenesis *(*[@r43]; [@r32]; [@r30]; [@r12]; [@r36]; [@r13]; [@r37]). Although the function of these genes in humans is not well-known, their roles in the progression of mouse spermatogenesis ([@r43]; [@r12]; [@r36]; [@r13]; [@r38]) led us to hypothesize that they were likely to have the same roles in humans. To test this hypothesis, we compared the expression levels of these genes in testicular tissue samples of infertile men with two distinct histological patterns of spermatogenic failure (MA and SCOS) - our case group - to the levels observed in a control group including men with complete spermatogenesis (obstructive azoospermia).

Given that there was no germ cell in the testicular tissue samples of SCOS patients and all four *TEX* genes are germ cell-specific, down-regulation of these genes was expected. This observation is in line with the findings in mice, in which the lack of these genes disrupts the development of meiosis, resulting in male infertility ([@r43]; [@r12]; [@r36]; [@r13]; [@r37]). The similar expression pattern and sequence conservation of *TEX11* seen in mice, humans, and pigs indicate that this gene is highly conserved and may have an important role in mammalian testicular function, including spermatogenesis ([@r43]; [@r32]; [@r30]). *TEX11* expression in testis is correlated with the onset of spermatogenesis and is restricted to spermatocytes and round spermatids ([@r32]). Stage-specific expression of *TEX11* in porcine meiotic germ cells is in agreement with findings in mice, where the lack of *Tex11* disturbs the progression of meiosis and thus results in infertility. The loss of function of *Tex11* in *Tex11-*null mice resulted in meiotic arrest and deletion of spermatocytes ([@r38]). In summary, the expression pattern of *Tex11* is highly preserved in rodents and higher mammals such as pigs and humans ([@r32]).

[@r39] demonstrated that the frequency of rare *TEX11* mutations is significantly higher in azoospermic men, suggesting that *TEX11* is essential for human spermatogenesis and mutations in this single X-linked gene is the cause of infertility in \~1% of azoospermic men. The authors also reported that the level of *TEX11* protein must be above a critical threshold for meiosis to progress, and that low-expressing *TEX11* alleles may thus result in human male infertility. [@r40] hypothesized that mutations in human *TEX11* disrupt the formation and function of the synaptonemal complex, resulting in disturbance of pachytene synapsis, meiotic arrest, and azoospermia. The authors reported that hemizygous *TEX11* mutations were a common cause of meiotic arrest and azoospermia in infertile men.

Our results showed that *TEX11* expression was significantly decreased in MA patients when compared to controls. As dysfunction of *TEX11* results in meiotic arrest and sterility in mice ([@r1]; [@r38]; [@r30]), impairment of spermatogenesis and maturation arrest in this group may be linked to *TEX11* down-regulation. This down-regulation was significantly more pronounced in SCOS patients than in patients with MA. Our results confirmed the involvement of *TEX11* in human spermatogenesis. Furthermore, our findings indicated that expression of this gene is required for the completion of spermatogenesis.

*Tex12* expression is limited to meiotic cell division and its promoter, like many other germ cell-specific genes, is quenched in somatic cells by transcription factor E2F6 ([@r25]). Previous studies showed that *TEX12* localizes to the central element of the synaptonemal complex. Their results also revealed that without *TEX12*, the synaptonemal complex lacks a correct central element structure, synapsis cannot complete, and meiotic recombination and crossing-over do not occur ([@r13]). Since loss of *TEX12* results in the inaccurate assembly of the synaptonemal complex and non-chromosomal synapsis ([@r13]), reduced expression of this gene in the MA group in relation to the control group was expected; however, our results did not reveal a significant difference in expression between these two groups.

Previous studies of *Tex15* in mice showed this gene is necessary for chromosomal synapsis, DSB repair, and meiotic recombination during meiosis; therefore, *TEX15* is thought of as a possible factor in spermatogenic failure risk ([@r37]). [@r23] showed that a nonsense mutation in *TEX15* is the cause of spermatogenic defect in familial cases of teratozoospermia and infertility. Immunohistochemistry confirmed these findings showing high levels of expression in germ cells and low levels of expression in Sertoli cells. The tests also revealed that *Tex15* knock-out produced spermatogenesis meiotic arrest and severe reduction in testicular size. Therefore, we expected to observe down-regulation of *TEX15* in the MA group when compared to controls. However, our results did not show any significant difference. This may possibly be due to high levels of expression in spermatogonia and early spermatocytes in the testicular tissue of MA patients. Previous studies have shown spermatogenic disruption in *Tex14* knockout mice before the first meiotic division due to loss of intercellular bridges ([@r3]; [@r12]; [@r11]). Moreover, a study on *Tex14* mutant pigs showed that *Tex14* is also essential for the completion of spermatogenesis in pigs ([@r28]). Although *TEX14* localizes to intercellular bridges of both female and male mice germ cells, disruption of this gene leads to sterility only in males ([@r5]; [@r12]). The comparison of *TEX14* expression between control and MA groups showed that *TEX14* expression had a significant decrease in MA samples. As dysfunction of *TEX14* results in meiotic arrest and sterility in mice ([@r12]; [@r11]; [@r36]), impairment of spermatogenesis and maturation arrest may be linked to the down-regulation of *TEX14*. These results were confirmed by immunohistochemistry, with *TEX14* expressed in type A spermatogonia, primary spermatocytes, and early round spermatids in control samples. Conversely, this protein was absent or hardly visible in type A spermatogonia, primary spermatocytes, and early round spermatids of MA samples. These results support the possibility that *TEX14* under-expression in MA patients is etiologic, suggesting that the low expression of this protein in these patients is unlikely to be caused by the lack of germ cells.

CONCLUSION
==========

This study demonstrated that *TEX11, TEX12, TEX14* and *TEX15* are essential for the completion of spermatogenesis. Down-regulation of these genes, especially *TEX14* and *TEX11*, may lead to impaired spermatogenesis in infertile men. Studies on other independent sample sets are required to confirm this association.
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